COMMUNIQUÉS West-GlobeNewswire

Diverge Health adds Oakland Southfield Physicians in Michigan to List of Physician Organization Partners
16/04/2026
SOUTHFIELD, Mich., April 16, 2026 (GLOBE NEWSWIRE) -- Diverge Health, a value-based care enabler for Medicaid, today announced a partnership with Oakland Southfield Physicians (OSP), a leading Southeast Michigan [...]
Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership
16/04/2026
Company targets one of the largest and most complex water safety markets in the U.S. to accelerate growth. SOUTH ORANGE, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology [...]
Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
16/04/2026
SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced that it will share six abstracts, including two podium [...]
Mapi Pharma to Present Efficacy (EDSS) Data from Glatiramer Acetate Depot Long-Acting Injection Studies in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS) at AAN 2026
16/04/2026
Poster scheduled for presentation on Tuesday, April 21, 8:00 AM - 9:00 AM CDT NESS ZIONA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development [...]
Confidential Care to Provide BraveMind Virtual Reality Treatment to Veterans
16/04/2026
STAMFORD, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Confidential Care in Wasilla, Alaska, is the country’s latest medical facility to partner with the national nonprofit SoldierStrong to provide a groundbreaking virtual [...]
Evaxion concludes Annual General Meeting
16/04/2026
COPENHAGEN, Denmark, April 16, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, held its Annual General Meeting today [...]
Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms
16/04/2026
First-quarter 2026 revenue reached €384m : +7.7% at constant exchange rate and scope (CERS) vs Q1 2025 +2.2% at actual rates impacted by significant currency headwinds Balanced growth in both segments : companion animal [...]
Virbac: forte croissance de +7,7 % au premier trimestre 2026 à pcc, portée par la croissance à deux chiffres de nos plateformes prioritaires Supercharge⁴
16/04/2026
Le chiffre d'affaires du premier trimestre 2026 a atteint 384 M€ : +7,7 % à taux de change et périmètre constants par rapport au T1 2025. +2,2 % à taux réels, impactés par des effets de change significativement [...]
NBPure Launches at Target, Marking Major Retail Expansion
16/04/2026
PHOENIX, April 16, 2026 (GLOBE NEWSWIRE) -- NBPure, a trusted leader in gut-first wellness for more than 28 years, today announced its expansion into Target, a significant milestone in the brand’s continued growth and [...]
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
16/04/2026
-- Partnership with AMI Technologies Positions FemaSeed ® as a First-Line Infertility Treatment in Israel, Expanding Market Access to Innovative Fertility Solutions -- ATLANTA, April 16, 2026 (GLOBE NEWSWIRE) -- Femasys [...]
MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer
16/04/2026
Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and survival data well above standard of care benchmarks 50,000 advanced NSCLC diagnoses in the U.S. [...]
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
16/04/2026
TORONTO, Ontario and HAIFA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (" NurExone " or the " Company "), a biopharmaceutical company developing exosome-based [...]
Dr. Falk Pharma and Renexxion Announce Late-Breaker Oral Presentation of Global Phase 2b Gastroparesis Results at Digestive Disease Week (DDW) 2026
16/04/2026
FREIBURG, Germany and ROSCREA, Ireland, April 16, 2026 (GLOBE NEWSWIRE) -- Dr. Falk Pharma GmbH (“Dr. Falk Pharma”), a research-based pharmaceutical company specializing in digestive and metabolic medicine, and [...]
Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026
16/04/2026
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX) (“Ardelyx” or the “Company”), a commercial-stage biopharmaceutical company focused on [...]
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway
16/04/2026
Company and Laboratory Partner Believe Properly Documented Claims Are Positioned for Payment Under Existing $300 CMS Reimbursement Rate The Medicare Administrative Contractor (MAC) responsible for processing inFoods® [...]
Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors
16/04/2026
BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large [...]
MIMEDX Announces Restructuring and Cost Reduction Initiative
16/04/2026
Company Expects to Realize Annualized Savings of Approximately $40 Million MARIETTA, Ga., April 16, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced a series of cost [...]
Helsinn appoints Giacomo Braglia to the Board of Directors
16/04/2026
Lugano, Switzerland – April 16 th , 2026 – Helsinn Healthcare SA (“Helsinn”), a global pharmaceutical group focused on supporting patients with cancer and chronic diseases, is pleased to announce the appointment of [...]
VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder Approval
16/04/2026
Transaction Delivers Fully Consolidated, Revenue-Generating, Aviation Business with Accelerating Growth Positions VTAK for Scalable Expansion in Regional Air Mobility Ahead of eVTOL Commercialization FORT MILL, S.C., [...]

Pages